NEW YORK, May 16, 2015 (GLOBE NEWSWIRE) -- The Rosen Law Firm, P.A., a global investor rights law firm, reminds purchasers of Accelerate Diagnostics, Inc. (Nasdaq:AXDX) securities from March 7, 2014 through February 17, 2015 of the important May 18, 2015 lead plaintiff deadline in the class action filed by the firm. The lawsuit seeks to recover damages for Accelerate Diagnostics investors under the federal securities laws.
To join the Accelerate Diagnostics class action, go to the firm's website at http://www.rosenlegal.com/cases-546.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action. The lawsuit is pending in the U.S. District Court for the District of Arizona.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, Defendants misrepresented and/or failed to disclose to investors that Accelerate Diagnostics' main product—the ID/AST system—formally known as the BACcel system, requires a positive blood culture to diagnose pathogens in a blood sample. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 18, 2015. If you wish to join the litigation, go to the firm's website at http://www.rosenlegal.com/cases-546.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.
The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar outcome.